Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care

Show other versions (1)

<p>Abstrak<br />Latar belakang: Hasil uji klinik terdahulu terhadap artemisinin-naftokuin (ANT) dosis sekali minum pada pengobatan pasien dewasa dengan malaria tanpa komplikasi menunjukkan aman, dapat ditoleransi, dan <br />sangat efektif. Data tambahan dibutuhkan untuk verifikasi...

Full description

Bibliographic Details
Main Authors:	Hadjar Siswantoro, Armedy Ronny Hasugian, Emiliana Tjitra
Format:	Article
Language:	English
Published:	Badan Penelitian dan Pengembangan Kesehatan 2015-01-01
Series:	Health Science Journal of Indonesia
Subjects:	malaria, artemisinin-naphthoquine, dihydroartemisinin-piperaquine, primary health care.
Online Access:	http://ejournal.litbang.kemkes.go.id/index.php/HSJI/article/view/3598

Similar Items

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Efficacy and safety of artemisinin-naphthoquine <it>versus</it> dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia
by: Tjitra Emiliana, et al.
Published: (2012-06-01)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
by: Bui Quang Phuc, et al.
Published: (2017-04-01)

Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine Combination at Primary Health Care
by: Lambok Siahaan
Published: (2022-06-01)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
by: Benjamin Abuaku, et al.
Published: (2023-01-01)

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated <it>Plasmodium falciparum</it> malaria in India
by: Gargano Nicola, et al.
Published: (2012-07-01)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
by: Souleymane Dama, et al.
Published: (2018-10-01)

Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea
by: Livingstone Tavul, et al.
Published: (2018-10-01)

Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients
by: Wanting Wu, et al.
Published: (2019-05-01)

Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated <it>falciparum</it> malaria in calabar, Nigeria
by: Meremikwu Martin M, et al.
Published: (2012-12-01)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
by: Jean Popovici, et al.
Published: (2018-08-01)

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated <it>Plasmodium falciparum</it> malaria in south-central Vietnam
by: Thanh Nguyen, et al.
Published: (2012-06-01)

Choreoathetosis – an unusual adverse effect of dihydroartemisinin-piperaquine: a case report
by: Benjamin Momo Kadia, et al.
Published: (2017-12-01)

Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
by: Roland Nnaemeka Okoro, et al.
Published: (2023-01-01)

Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania
by: Karol J. Marwa, et al.
Published: (2021-11-01)

Reproductive and endocrine effects of artemisinin, piperaquine, and artemisinin-piperaquine combination in rats
by: Xiaobo Li, et al.
Published: (2022-10-01)

Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
by: Qingyun Huang, et al.
Published: (2010-12-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Efficacy and Safety of Artemisinin-Piperaquine for the Treatment of Uncomplicated Malaria: A Systematic Review
by: Qi Wang, et al.
Published: (2020-09-01)

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania
by: Celine I. Mandara, et al.
Published: (2019-03-01)

Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
by: Brioni R. Moore, et al.
Published: (2017-10-01)

Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial
by: Esperança Sevene, et al.
Published: (2019-08-01)

Efficacy and safety of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials
by: Dawit Getachew Assefa, et al.
Published: (2021-04-01)

Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial
by: Abel Kakuru, et al.
Published: (2020-08-01)

Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trials
by: Esther Nthenya Muthoka, et al.
Published: (2023-10-01)

Intravenous artesunate plus oral dihydroartemisinin–piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia
by: Silvester Alexandro Sikora, et al.
Published: (2019-12-01)

Therapeutic efficacy of dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium vivax malaria in Seacha area, Arbaminch Zuria District, South West Ethiopia
by: Hussein Mohammed, et al.
Published: (2022-11-01)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
by: Pauline Byakika-Kibwika, et al.
Published: (2019-12-01)

Implementation research of a cluster randomized trial evaluating the implementation and effectiveness of intermittent preventive treatment for malaria using dihydroartemisinin-piperaquine on reducing malaria burden in school-aged children in Tanzania: methodology, challenges, and mitigation
by: Geofrey Makenga, et al.
Published: (2023-01-01)

Mass Drug Administration With Artemisinin-Piperaquine for the Elimination of Residual Foci of Malaria in São Tomé Island
by: Mingqiang Li, et al.
Published: (2021-07-01)

Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial
by: Thandile Nkosi-Gondwe, et al.
Published: (2023-04-01)

Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
by: Elizabeth Davlantes, et al.
Published: (2018-04-01)

Efficacies of DHA–PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan
by: Abdelrahim O. Mohamed, et al.
Published: (2017-04-01)

Multiple episodes of Plasmodium malariae despite antimalarial treatment: “Quartana te teneat”?
by: Alberto Rizzo, et al.
Published: (2023-11-01)

Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial
by: Thandile Gondwe, et al.
Published: (2018-07-01)

Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China–Myanmar, Thailand–Myanmar, and Thailand–Cambodia borders
by: Run Ye, et al.
Published: (2022-04-01)

Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized controlled trial
by: Jean-Bertin Bukasa Kabuya, et al.
Published: (2021-11-01)

How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review
by: Sophie Moss, et al.
Published: (2022-06-01)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
by: Lorenz von Seidlein, et al.
Published: (2020-01-01)